Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials

Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials

Background: Diabetes mellitus (DM) significantly impacts global health due to its complications and the economic burden it places on healthcare systems. The rise of novel once-weekly diabetes medications with different mechanisms of action necessitates an evaluation of their relative efficacy and sa...

Full description

Saved in:
Bibliographic Details
Main Authors: Hazem Ayesh, Sajida Suhail, Suhail Ayesh, Kevin Niswender
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Biomedicines
Subjects:
diabetes management
once-weekly insulin
GLP-1/GIP receptor agonists
HbA1c reduction
treatment tolerability
Online Access:https://www.mdpi.com/2227-9059/12/9/1943
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/12/9/1943

Similar Items